Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 349

Baidu catches Kitt.AI

Baidu has paid an undisclosed amount to acquire Kitt.Ai, an Amazon Alexa Fund-backed AI language technology developer.

Jul 7, 2017

Sienna to scratch IPO itch

Topical skin treatment developer and JLabs graduate Sienna Biopharmaceuticals has filed for a $74.8m initial public offering, after raising $86m in venture funding.

Jul 7, 2017

Jawbone locks up as liquidation process begins

The Deutsche Telekom-backed wearable fitness tracker developer was once valued at more than $3bn, but has now begun liquidation proceedings.

Jul 7, 2017

MyRepublic begins journey to IPO

Sinar Mas and Dian Swastatika Sentosa-backed internet service provider MyRepublic is targeting the end of 2018 for an initial public offering, its CEO has said.

Jul 6, 2017

Unchained Labs links to Novo in $13m round

Existing investor Novo Ventures contributed to a series C round announced alongside Unchained Labs' acquisition of protein measurement device maker Trinean.

Jul 5, 2017

Roche eats up MySugr

The pharmaceutical company has bought diabetes management platform MySugr for an undisclosed sum, two years after its corporate venturing unit backed a $4.8m seed round.

Jul 5, 2017

InfoScout gets on Market Track in acquisition deal

Dunnhumby Ventures has exited consumer analytics provider InfoScout in a cash and stock purchase by business intelligence company Market Track.

Jul 5, 2017

Snapdeal turns down nine-figure Flipkart offer

The corporate-backed online marketplace is reportedly holding out for $1bn, having rejected an acquisition offer of between $550m and $900m.

Jul 5, 2017

Kinvey gives way to Progress in $49m acquisition

Progress Software has acquired business app development platform Kinvey, which had raised almost $18m from backers including NTT Docomo Ventures and Verizon Ventures.

Jul 4, 2017

Clementia to form $115m IPO

The bone disease therapy developer had raised $92.5m from investors including UCB Pharma across two rounds in 2015.

Jul 4, 2017
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here